Drug safety debates focus on proposed changes to FDA

06/5/2007 | Forbes

The drug safety debate has attracted doctors, lawyers and legislators to comment on FDA operations and proposed legislation to reform the agency. The drug industry supports the Kennedy-Enzi bill requiring more transparency for clinical trials and giving FDA added authority to change drug labels and require post-market studies. Others are calling for a separate center to monitor drugs on the market or a reformed budget to lessen industry ties.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President - Government Products
Health Alliance Plan
Detroit, MI
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC